{"id":"https://openalex.org/A5084500752","orcid":"https://orcid.org/0009-0006-7325-4257","observed_orcids":["https://orcid.org/0009-0006-7325-4257"],"display_name":"Rolf Wagenaar","raw_author_names":["Rolf J Wagenaar","Rolf Wagenaar"],"full_name":"Rolf J Wagenaar","works_count":3,"cited_by_count":4,"summary_stats":{"2yr_mean_citedness":1.3333333333333333,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5084500752","orcid":"https://orcid.org/0009-0006-7325-4257","observed_orcids":["https://orcid.org/0009-0006-7325-4257"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210141406","ror":"https://ror.org/04n4q2213","display_name":"Basilea Pharmaceutica (Switzerland)","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210141406"]},"years":[2026,2025]}],"last_known_institutions":[{"id":"https://openalex.org/I4210141406","ror":"https://ror.org/04n4q2213","display_name":"Basilea Pharmaceutica (Switzerland)","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210141406"]}],"topics":[{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","count":3,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","count":1,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","count":1,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","count":1,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","count":1,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","value":1.34e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11551","display_name":"Infective Endocarditis Diagnosis and Management","value":6.3e-06,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","value":5.3e-06,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","value":4.4e-06,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","value":2.6e-06,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9031420946121216},{"id":"2779443120","wikidata":"https://www.wikidata.org/wiki/Q650912","display_name":"Bacteremia","score":0.7964494228363037},{"id":"167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","score":0.6731517910957336},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.6677071452140808},{"id":"2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","score":0.4832342565059662}],"counts_by_year":[{"year":2025,"works_count":2,"oa_works_count":2,"cited_by_count":1},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":3}],"display_name_alternatives":["Rolf J Wagenaar","Rolf Wagenaar"],"block_key":"r wagenaar","works_api_url":"https://api.openalex.org/works?filter=author.id:A5084500752","awards_count":0,"updated_date":"2026-11-04T11:47:51","created_date":"2025-03-20T00:00:00"}